Cargando…

Using Pharmacogenetics of Direct Oral Anticoagulants to Predict Changes in Their Pharmacokinetics and the Risk of Adverse Drug Reactions

Dabigatran, rivaroxaban, apixaban, and edoxaban are direct oral anticoagulants (DOACs) that are increasingly used worldwide. Taking into account their widespread use for the prevention of thromboembolism in cardiology, neurology, orthopedics, and coronavirus disease 2019 (COVID 19) as well as their...

Descripción completa

Detalles Bibliográficos
Autores principales:	Shnayder, Natalia A., Petrova, Marina M., Shesternya, Pavel A., Savinova, Alina V., Bochanova, Elena N., Zimnitskaya, Olga V., Pozhilenkova, Elena A., Nasyrova, Regina F.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8143539/ https://www.ncbi.nlm.nih.gov/pubmed/33922084 http://dx.doi.org/10.3390/biomedicines9050451

Ejemplares similares

The Role of Single-Nucleotide Variants of NOS1, NOS2, and NOS3 Genes in the Comorbidity of Arterial Hypertension and Tension-Type Headache
por: Shnayder, Natalia A., et al.
Publicado: (2021)

Pharmacogenetic testing in schizophrenia in real clinical practice: before or after antipsychotic -induced adverse drug reactions development?
por: Abdyrakhmanova, A., et al.
Publicado: (2022)

Candidate Genes and Proteomic Biomarkers of Serum and Urine in Medication-Overuse Headache
por: Shnayder, Natalia A., et al.
Publicado: (2021)

Blood and Urinary Biomarkers of Antipsychotic-Induced Metabolic Syndrome
por: Khasanova, Aiperi K., et al.
Publicado: (2022)

Therapeutic and Toxic Effects of Valproic Acid Metabolites
por: Shnayder, Natalia A., et al.
Publicado: (2023)

Candidate Genes Encoding Dopamine Receptors as Predictors of the Risk of Antipsychotic-Induced Parkinsonism and Tardive Dyskinesia in Schizophrenic Patients
por: Vaiman, Elena E., et al.
Publicado: (2021)

Pharmacogenetics to Avoid Adverse Drug Reactions
por: López-Fernández, Luis A.
Publicado: (2022)

Leukocyte Telomere Length as a Molecular Biomarker of Coronary Heart Disease
por: Zimnitskaya, Olga V., et al.
Publicado: (2022)

Pharmacogenetics of Anticoagulants
por: Rane, Anders, et al.
Publicado: (2010)

Cytokine Imbalance as a Biomarker of Intervertebral Disk Degeneration
por: Shnayder, Natalia A., et al.
Publicado: (2023)

The “Angiogenic Switch” and Functional Resources in Cyclic Sports Athletes
por: Balberova, Olga V., et al.
Publicado: (2021)

Pharmacogenetics to Avoid Adverse Reactions in Cardiology: Ready for Implementation?
por: García-González, Xandra, et al.
Publicado: (2021)

Genetic Factors of Nitric Oxide’s System in Psychoneurologic Disorders
por: Nasyrova, Regina F., et al.
Publicado: (2020)

The Role of Polymorphisms in Collagen-Encoding Genes in Intervertebral Disc Degeneration
por: Trefilova, Vera V., et al.
Publicado: (2021)

The Role of Single Nucleotide Variants of NOS1, NOS2, and NOS3 Genes in the Development of the Phenotype of Migraine and Arterial Hypertension
por: Moskaleva, Polina V., et al.
Publicado: (2021)

Pharmacogenetics aspects of oral anticoagulants therapy
por: Militaru, FC, et al.
Publicado: (2015)

Cases of Adverse Reaction to Psychotropic Drugs and Possible Association with Pharmacogenetics
por: Piatkov, Irina, et al.
Publicado: (2012)

Pharmacogenetic Testing for Prevention of Severe Cutaneous Adverse Drug Reactions
por: Chang, Chih-Jung, et al.
Publicado: (2020)

Clinical Experience of High Frequency and Low Frequency TENS in Treatment of Diabetic Neuropathic Pain in Russia
por: Al-Zamil, Mustafa, et al.
Publicado: (2022)

Association of a Single-Nucleotide Variant rs11100494 of the NPY5R Gene with Antipsychotic-Induced Metabolic Disorders
por: Dobrodeeva, Vera S., et al.
Publicado: (2022)

Single-Nucleotide Polymorphisms as Biomarkers of Antipsychotic-Induced Akathisia: Systematic Review
por: Nasyrova, Regina F., et al.
Publicado: (2023)

Pharmacogenetic studies with oral anticoagulants. Genome-wide association studies in vitamin K antagonist and direct oral anticoagulants
por: Cullell, Natalia, et al.
Publicado: (2018)

Pharmacogenetics for severe adverse drug reactions induced by molecular‐targeted therapy
por: Udagawa, Chihiro, et al.
Publicado: (2020)

Role of Pharmacogenetics in Adverse Drug Reactions: An Update towards Personalized Medicine
por: Micaglio, Emanuele, et al.
Publicado: (2021)

Association of Single-Nucleotide Polymorphisms Rs2779249 (chr17:26128581 C>A) and Rs rs2297518 (chr17: chr17:27769571 G>A) of the NOS2 Gene with Tension-Type Headache and Arterial Hypertension Overlap Syndrome in Eastern Siberia
por: Alyabyeva, Polina V., et al.
Publicado: (2023)

Pharmacogenetic Foundations of Therapeutic Efficacy and Adverse Events of Statins
por: Arrigoni, Elena, et al.
Publicado: (2017)

Expression Profile of miRs in Mesial Temporal Lobe Epilepsy: Systematic Review
por: Yakovleva, Kristina D., et al.
Publicado: (2022)

Amyotrophic Lateral Sclerosis Mimic Syndrome in a 24-Year-Old Man with Chiari 1 Malformation and Syringomyelia: A Clinical Case
por: Al-Zamil, Mustafa, et al.
Publicado: (2023)

Association of the ACTN3 Gene’s Single-Nucleotide Variant Rs1815739 (R577X) with Sports Qualification and Competitive Distance in Caucasian Athletes of the Southern Urals
por: Balberova, Olga V., et al.
Publicado: (2023)

Effects of Pharmacogenetics on the Pharmacokinetics and Pharmacodynamics of Tamoxifen
por: de Vries Schultink, Aurelia H. M., et al.
Publicado: (2015)

Insights into the Pharmacogenetics of Tacrolimus Pharmacokinetics and Pharmacodynamics
por: Brunet, Mercè, et al.
Publicado: (2022)

Genetic Biomarkers of Antipsychotic-Induced Prolongation of the QT Interval in Patients with Schizophrenia
por: Vaiman, Elena E., et al.
Publicado: (2022)

Pharmacogenetics of Direct Oral Anticoagulants: A Systematic Review
por: Raymond, Johanna, et al.
Publicado: (2021)

Prospects for the Personalized Multimodal Therapy Approach to Pain Management via Action on NO and NOS
por: Shnayder, Natalia A., et al.
Publicado: (2021)

Ticagrelor: Pharmacokinetic, Pharmacodynamic and Pharmacogenetic Profile: An Update
por: Teng, Renli
Publicado: (2015)

Pharmacokinetics, Pharmacodynamics and Pharmacogenetics of Tacrolimus in Kidney Transplantation
por: Yu, Meng, et al.
Publicado: (2018)

Real-World Efficiency of Pharmacogenetic Screening for Carbamazepine-Induced Severe Cutaneous Adverse Reactions
por: Chen, Zhibin, et al.
Publicado: (2014)

Pharmacokinetic and pharmacogenetic determinants of the activity and toxicity of irinotecan in metastatic colorectal cancer patients
por: Rouits, E, et al.
Publicado: (2008)

Pharmacogenetics of Drug Metabolism: The Role of Gene Polymorphism in the Regulation of Doxorubicin Safety and Efficacy
por: Bagdasaryan, Alina A., et al.
Publicado: (2022)

Genetic Testing Before Anticoagulation? A Systematic Review of Pharmacogenetic Dosing of Warfarin
por: Kangelaris, Kirsten Neudoerffer, et al.
Publicado: (2009)

Cannot write session to /tmp/vufind_sessions/sess_7jfmbvft16uiklhv8up37t31sp